Therapeutically Targeting the Consequences of HIV-1-associated Gastrointestinal Dysbiosis: Implications for Neurocognitive and Affective Alterations

Overview

Journal Pharmacol Biochem Behav

Publisher Elsevier

Specialties Biochemistry
Pharmacology
Psychology
Social Sciences

Date 2023 Jun 30

PMID 37390973

Authors

Mason T Rodriguez

Kristen A McLaurin

Michael Shtutman

Jason L Kubinak

Charles F Mactutus

Rosemarie M Booze

Affiliations

Soon will be listed here.

Abstract

Approximately 50 % of the individuals living with human immunodeficiency virus type 1 (HIV-1) are plagued by debilitating neurocognitive impairments (NCI) and/or affective alterations. Sizeable alterations in the composition of the gut microbiome, or gastrointestinal dysbiosis, may underlie, at least in part, the NCI, apathy, and/or depression observed in this population. Herein, two interrelated aims will be critically addressed, including: 1) the evidence for, and functional implications of, gastrointestinal microbiome dysbiosis in HIV-1 seropositive individuals; and 2) the potential for therapeutically targeting the consequences of this dysbiosis for the treatment of HIV-1-associated NCI and affective alterations. First, gastrointestinal microbiome dysbiosis in HIV-1 seropositive individuals is characterized by decreased alpha (α) diversity, a decreased relative abundance of bacterial species belonging to the Bacteroidetes phylum, and geographic-specific alterations in Bacillota (formerly Firmicutes) spp. Fundamentally, changes in the relative abundance of Bacteroidetes and Bacillota spp. may underlie, at least in part, the deficits in γ-aminobutyric acid and serotonin neurotransmission, as well as prominent synaptodendritic dysfunction, observed in this population. Second, there is compelling evidence for the therapeutic utility of targeting synaptodendritic dysfunction as a method to enhance neurocognitive function and improve motivational dysregulation in HIV-1. Further research is needed to determine whether the therapeutics enhancing synaptic efficacy exert their effects by altering the gut microbiome. Taken together, understanding gastrointestinal microbiome dysbiosis resulting from chronic HIV-1 viral protein exposure may afford insight into the mechanisms underlying HIV-1-associated neurocognitive and/or affective alterations; mechanisms which can be subsequently targeted via novel therapeutics.

References

Leon A, Heo M . Sample Sizes Required to Detect Interactions between Two Binary Fixed-Effects in a Mixed-Effects Linear Regression Model. Comput Stat Data Anal. 2010; 53(3):603-608. PMC: 2678722. DOI: 10.1016/j.csda.2008.06.010. View

Pinto-Cardoso S, Klatt N, Reyes-Teran G . Impact of antiretroviral drugs on the microbiome: unknown answers to important questions. Curr Opin HIV AIDS. 2017; 13(1):53-60. PMC: 5718259. DOI: 10.1097/COH.0000000000000428. View

Wang Z, Usyk M, Sollecito C, Qiu Y, Williams-Nguyen J, Hua S . Altered Gut Microbiota and Host Metabolite Profiles in Women With Human Immunodeficiency Virus. Clin Infect Dis. 2019; 71(9):2345-2353. PMC: 7713676. DOI: 10.1093/cid/ciz1117. View

Brenchley J, Price D, Schacker T, Asher T, Silvestri G, Rao S . Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006; 12(12):1365-71. DOI: 10.1038/nm1511. View

Chiba M, Hensleigh M, Nishime J, Balani S, Lin J . Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor. Drug Metab Dispos. 1996; 24(3):307-14. View

Qing Y, Xie H, Su C, Wang Y, Yu Q, Pang Q . Gut Microbiome, Short-Chain Fatty Acids, and Mucosa Injury in Young Adults with Human Immunodeficiency Virus Infection. Dig Dis Sci. 2018; 64(7):1830-1843. DOI: 10.1007/s10620-018-5428-2. View

Setchell K, Borriello S, Hulme P, KIRK D, Axelson M . Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr. 1984; 40(3):569-78. DOI: 10.1093/ajcn/40.3.569. View

Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L . A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2016; 23(1):107-113. DOI: 10.1038/nm.4236. View

Imahashi M, Ode H, Kobayashi A, Nemoto M, Matsuda M, Hashiba C . Impact of long-term antiretroviral therapy on gut and oral microbiotas in HIV-1-infected patients. Sci Rep. 2021; 11(1):960. PMC: 7806981. DOI: 10.1038/s41598-020-80247-8. View

10.

Nowak R, Bentzen S, Ravel J, Crowell T, Dauda W, Ma B . Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected in Nigeria. AIDS. 2017; 31(6):857-862. PMC: 5342931. DOI: 10.1097/QAD.0000000000001409. View

11.

McLaurin K, Li H, Booze R, Mactutus C . Disruption of Timing: NeuroHIV Progression in the Post-cART Era. Sci Rep. 2019; 9(1):827. PMC: 6351586. DOI: 10.1038/s41598-018-36822-1. View

12.

Tuscher J, Luine V, Frankfurt M, Frick K . Estradiol-Mediated Spine Changes in the Dorsal Hippocampus and Medial Prefrontal Cortex of Ovariectomized Female Mice Depend on ERK and mTOR Activation in the Dorsal Hippocampus. J Neurosci. 2016; 36(5):1483-9. PMC: 4737764. DOI: 10.1523/JNEUROSCI.3135-15.2016. View

13.

Rajilic-Stojanovic M, Heilig H, Tims S, Zoetendal E, de Vos W . Long-term monitoring of the human intestinal microbiota composition. Environ Microbiol. 2013; . DOI: 10.1111/1462-2920.12023. View

14.

Bravo J, Forsythe P, Chew M, Escaravage E, Savignac H, Dinan T . Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011; 108(38):16050-5. PMC: 3179073. DOI: 10.1073/pnas.1102999108. View

15.

Somsouk M, Estes J, Deleage C, Dunham R, Albright R, Inadomi J . Gut epithelial barrier and systemic inflammation during chronic HIV infection. AIDS. 2014; 29(1):43-51. PMC: 4444362. DOI: 10.1097/QAD.0000000000000511. View

16.

Corasaniti M, Amantea D, Russo R, Piccirilli S, Leta A, Corazzari M . 17beta-estradiol reduces neuronal apoptosis induced by HIV-1 gp120 in the neocortex of rat. Neurotoxicology. 2005; 26(5):893-903. DOI: 10.1016/j.neuro.2005.01.019. View

17.

Setchell K, Cole S . Method of defining equol-producer status and its frequency among vegetarians. J Nutr. 2006; 136(8):2188-93. DOI: 10.1093/jn/136.8.2188. View

18.

Cysique L, Brew B . Comorbid depression and apathy in HIV-associated neurocognitive disorders in the era of chronic HIV infection. Handb Clin Neurol. 2019; 165:71-82. DOI: 10.1016/B978-0-444-64012-3.00006-X. View

19.

Rocafort M, Noguera-Julian M, Rivera J, Pastor L, Guillen Y, Langhorst J . Evolution of the gut microbiome following acute HIV-1 infection. Microbiome. 2019; 7(1):73. PMC: 6511141. DOI: 10.1186/s40168-019-0687-5. View

20.

Saylor D, Dickens A, Sacktor N, Haughey N, Slusher B, Pletnikov M . HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment. Nat Rev Neurol. 2016; 12(4):234-48. PMC: 4937456. DOI: 10.1038/nrneurol.2016.27. View